Cav1.4 calcium channels control cytokine production by human peripheral TH17 cells and psoriatic skin-infiltrating T cells.

Abstract Background Type-17 inflammation characterizes psoriasis, a chronic skin disease. As several inflammatory cytokines contribute to psoriasis pathogenesis, inhibiting the simultaneous production of these cytokines in Th17-cells may be beneficial in psoriasis. We found that Cav1.4, encoded by CACNA1F, was the only Cav1 calcium channel expressed in Th17-cells. Objective We investigated the role of Cav1.4 expression in early Th17-activation events and effector functions, as well as its association with Th17 signature genes in lesional psoriatic (LP) skins. Methods Transcriptional gene signatures associated with CACNA1F expression were examined in LP skins by RT-PCR and in situ hybridization. Cav1 inhibitor and/or shRNA lentivectors were used to assess the contribution of Cav1.4 on Th17 activation and effector functions in a 3D skin reconstruction model. Results CACNA1F expression correlated with inflammatory cytokine expression that characterizes LP skins and was preferentially associated with RORC expression in CD4+ and CD4- cells from LP biopsies. Nicardipine, a Cav1 channel antagonist, markedly reduced inflammatory cytokine production by Th17-cells from blood or LP skin. This was associated with decreased TCR-induced early calcium events at cell membrane and proximal signaling events. The knockdown of Cav1.4 in Th17-cells impaired cytokine production. Finally, Cav1 inhibition reduced the expression of the keratinocyte genes characteristic of Th17-mediated psoriasis inflammation in human skin equivalents. Conclusion Cav1.4 channels promote Th17-cell functions both at the periphery and in inflammatory psoriatic skin.